Drug developers have successfully tackled general anxiety with a number of innovations. But social anxiety disorder, which can trigger debilitating fear, self-consciousness or nervousness during ...
The FDA recently OK'd Gilead's novel HIV combo med, and cell therapy deals have fallen dramatically in two years.
More than 25 years after it was declared eliminated, measles has surged back. But drug R&D is still in early stages and up ...
Chinese clinical trials have become synonymous with speed and savings, but questions have surfaced about the price of those advantages. Reports surfaced over the summer of three deaths in Chinese ...
Dealmaking in the autoimmune space is thriving as biotechs chase new targets with the potential to treat more conditions.
Wall Street analysts believe that a more cautious approach to manufacturing, study enrollment and side effect management ...
Gilead’s new “Up to Date” campaign uses humor and dating scenarios to reach Black communities amid persistent gaps in HIV ...
CAR-T’s commercial challenge isn’t making bigger batches. It’s making thousands of patient-specific manufacturing runs behave ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results